Correction to Lancet Oncol 2019; 20: 816-26

No authors listed

Published Erratum

No authors listed. Lancet Oncol. 2019 Jun.

. 2019 Jun;20(6):e293.

doi: 10.1016/S1470-2045(19)30292-X. Epub 2019 May 10.

No abstract available

Erratum for

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.
Tamura K, Tsurutani J, Takahashi S, Iwata H, Krop IE, Redfern C, Sagara Y, Doi T, Park H, Murthy RK, Redman RA, Jikoh T, Lee C, Sugihara M, Shahidi J, Yver A, Modi S. Tamura K, et al. Lancet Oncol. 2019 Jun;20(6):816-826. doi: 10.1016/S1470-2045(19)30097-X. Epub 2019 Apr 29. Lancet Oncol. 2019. PMID: 31047803 Clinical Trial.